On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Cellply SRL's own share of each project, not the project's full budget.
- Horizon 2020€2.4M · 2 projects
- Horizon Europe€259k · 1 project
Projects
3 EU-funded projects, newest first. Cellply SRL led 2 of them as coordinator. Each links to the official record.
- OncoProToolsPartner
Protease‐guided tumor targeting tools to revolutionize cancer diagnosis and treatment.
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€259ktheir share - ONCOSMARTCoordinator
ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics
Horizon 2020 · 2018–2021 · Project on CORDIS ↗
€2.3Mtheir share - OncosmartCoordinator
ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics
Horizon 2020 · 2016–2017 · Project on CORDIS ↗
€50ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
- Kobenhavns UniversitetDenmark · 1 shared project
- Alma Mater Studiorum - Universita di BolognaItaly · 1 shared project
- Technische Universitaet DresdenGermany · 1 shared project
- Universiteit AntwerpenBelgium · 1 shared project
- Universitaet BernSwitzerland · 1 shared project
- Johannes Gutenberg-Universitat MainzGermany · 1 shared project
- Universidad Autonoma de MadridSpain · 1 shared project
- Helmholtz-Zentrum Dresden-Rossendorf eVGermany · 1 shared project
- Semmelweis EgyetemHungary · 1 shared project
- Faculdade de Farmácia da Universidade de LisboaPortugal · 1 shared project
- Fox Biosystems NVBelgium · 1 shared project
- European Cancer Patient CoalitionBelgium · 1 shared project
- Cancer Patients EuropeBelgium · 1 shared project
- Cromed Kutato Es Szolgaltato Kozpontok KftHungary · 1 shared project
- Insel Gruppe AGSwitzerland · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- cells technologies
- drug discovery
- hematology
- immunology
- immunotherapy
- leukemia
- oncology
- personalized medicine
- public health
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.